To evaluate the efficacy and safety of two concentrations of PRT-2761 as a topical ophthalmic solution for the treatment of the signs and symptoms of acute and chronic allergic conjunctivitis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Ocular Itching at 5, 7, and 10 Minutes Post CAC on Day 1
Timeframe: post CAC exposure at 5, 7, and 10 minutes post CAC on Day 1
Ocular Itching at 5, 7, and 10 Minutes Post CAC on Day 15
Timeframe: post CAC exposure at 5, 7, and 10 minutes post CAC on Day 15
Conjunctival Redness at 7, 15, and 20 Minutes Post CAC on Day 1
Timeframe: post CAC exposure at 7, 15, and 20 minutes post-CAC on Day 1.
Conjunctival Redness at 7, 15, and 20 Minutes Post CAC on Day 15
Timeframe: post CAC exposure at 7, 15, and 20 minutes post-CAC on Day 15.